China Life Capital
Overview
China Life Capital is the professional alternative investment platform for its parent, the state-owned China Life Insurance (Group) Company. It primarily engages in private equity, real estate, and infrastructure investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fairino (Suzhou) Robot Technology Co., Ltd. | Mar 2026 | Series C | Lead |
| Tripo AI | Jun 2026 | Series A Extension | Lead |
| Tripo AI | Jun 2026 | Series A+ / A++ | Co-investor |
| Xindi Digital Engineering System | Aug 2023 | Series D Extension | Lead |
| Vastai Technologies | Dec 2021 | Series B | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Life Capital based?
China Life Capital is headquartered in Beijing, China.
When was China Life Capital founded?
China Life Capital was founded in 2007.
How many portfolio companies does China Life Capital have?
China Life Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in China Life Capital's portfolio?
Portfolio companies visible on Caplight include Fairino (Suzhou) Robot Technology Co., Ltd., Tripo AI, Tripo AI, Xindi Digital Engineering System, Vastai Technologies.
What was China Life Capital's most recent investment shown here?
China Life Capital's most recent investment in this portfolio sample was in Tripo AI in 2026.
What sectors does China Life Capital focus on?
China Life Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, Frontier & Industrial Tech, Media, Entertainment & Gaming, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does China Life Capital focus on?
China Life Capital typically invests at the Mid stage.
What is China Life Capital's AUM?
China Life Capital's assets under management are estimated between $87.1B and $87.1B.